Vir Biotechnology (VIR) Ownership - Who Owns Vir Biotechnology?

Compare

1,514 Followers

Vir Biotechnology (VIR) Ownership Overview

10.72% Insiders

12.16% Mutual Funds

29.24% Other Institutional Investors

18.62% ETFs

29.26% Public Companies and Individual Investors

The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. Approximately 60.01% of the company’s stock is owned by Institutional Investors, 10.72% is owned by Insiders, and 29.26% is owned by Public Companies and Individual Investors.

The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. Approximately 41.40% of the company’s stock is owned by Institutional Investors, 10.72% is owned by Insiders, and 18.62% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Nov 18, 2025	Jason O'byrne	xxxxxxxxxxxxx	$37734
Nov 04, 2025	Vanina De Verneuil	xxxxxxxxxxxxx	$7999
Jul 17, 2025	Mark Eisner	xxxxxxxxxxxxx	$37106
Apr 04, 2025	Marianne De Backer	xxxxxxxxxxxxx	$473489

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,728,924	Insider	8.59%	127,129,836
12,397,457	Institution	7.76%	114,800,452
9,700,724	Institution	6.07%	89,828,704
8,460,919	Institution	5.29%	78,348,110
4,704,655	Institution	2.94%	43,565,105
1,487,763	Institution	0.93%	13,776,685
1,268,488	Institution	0.79%	11,746,199
1,160,346	Institution	0.73%	10,744,804
1,122,391	Insider	0.70%	10,393,341
1,073,822	Insider	0.67%	9,943,592

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
8,460,919	Institution	5.29%	78,348,110
1,487,763	Institution	0.93%	13,776,685
1,268,488	Institution	0.79%	11,746,199
1,160,346	Institution	0.73%	10,744,804
1,005,430	Institution	0.63%	9,310,282
605,270	Institution	0.38%	5,604,800
600,003	Institution	0.38%	5,556,028
504,482	Institution	0.32%	4,671,503
502,706	Institution	0.31%	4,655,058
440,000	Institution	0.28%	4,074,400

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core S&P Small Cap ETF	6,848,432	Institution	4.29%	63,416,480
Vanguard Total Stock Market ETF	3,497,089	Institution	2.19%	26,018,342
Vanguard Small-Cap ETF	2,526,416	Institution	1.58%	18,796,535
SPDR S&P BIOTECH ETF	2,277,389	Institution	1.43%	21,589,648
iShares Russell 2000 ETF	2,092,490	Institution	1.31%	19,376,457
Vanguard Small-Cap Growth ETF	1,401,919	Institution	0.88%	10,430,277
SPDR Portfolio S&P 600 Small Cap ETF	1,048,987	Institution	0.66%	9,944,397
Vanguard Extended Market ETF	1,017,785	Institution	0.64%	7,572,320
iShares Russell 2000 Value ETF	763,246	Institution	0.48%	7,067,658
iShares Biotechnology ETF	683,077	Institution	0.43%	6,325,293

FAQ

Who Owns Vir Biotechnology (VIR)?

According to the latest TipRanks data, approximately 29.24% of the company's stock is held by institutional investors, 10.72% is held by insiders, and 29.26% is held by retail investors.

What percentage of Vir Biotechnology (VIR) stock is held by institutional investors?

According to the latest TipRanks data, approximately 29.24% of Vir Biotechnology (VIR) stock is held by institutional investors.

What percentage of Vir Biotechnology (VIR) stock is held by retail investors?

According to the latest TipRanks data, approximately 29.26% of Vir Biotechnology (VIR) stock is held by retail investors.

Who owns the most shares of Vir Biotechnology (VIR)?

SVF Endurance (Cayman) Ltd owns the most shares of Vir Biotechnology (VIR).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.